Last Updated on September 7, 2024 by The Health Master
Drug recall
In a recent development, two major Indian pharmaceutical companies, Dr Reddy’s Laboratories and Lupin, have initiated drug recall for their products in the United States due to manufacturing irregularities.
The drug recall, mandated by the US Food and Drug Administration (USFDA), highlight the critical importance of quality control in the pharmaceutical industry.
Dr Reddy’s Drug Recall – Ibuprofen Tablets
Dr Reddy’s Laboratories, a leading Indian pharmaceutical company, has recalled multiple strengths of Ibuprofen tablets in the US market.
The drug recall was prompted by the discovery of impurities that exceeded the specified limits.
The affected lots were found to contain higher levels of an unknown impurity than allowed, potentially posing risks to patient safety.
Lupin Drug Recall – Cefixime Suspension
Lupin Pharmaceuticals, another prominent Indian drug maker, has also initiated a drug recall for its Cefixime Oral Suspension in the US.
The drug recall was triggered by the discovery that the affected lot was subpotent, meaning it contained a lower concentration of the active ingredient than intended.
Cefixime is a commonly used antibiotic.
Class II Drug Recall: Understanding the Implications
Both Dr Reddy’s and Lupin have initiated Class II drug recall for their products.
A Class II drug recall is a serious matter, indicating that the use or exposure to the affected products could lead to temporary or reversible adverse health consequences.
While the risk of serious adverse effects is low, the recalls underscore the need for vigilance in ensuring the safety and efficacy of pharmaceutical products.
Impact on the Pharmaceutical Industry
These recalls have significant implications for the pharmaceutical industry, particularly for Indian companies operating in the US market.
They highlight the importance of stringent quality control measures and adherence to regulatory standards.
Additionally, the recalls raise questions about the effectiveness of existing oversight mechanisms and the need for further improvements to prevent similar incidents in the future.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, including advice, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
Drug recall: B. Braun recalls Saline Solution due to this reason
Drug recall: Baxter recalls Heparin Sodium Injection Due to this reason
Drug Recall in India: A Growing Concern
Drug recall: Sanofi recalls Allegra, Combiflam suspensions due to this reason
Drug recall: Glenmark Recalls 114 Batches Of Hypokalemia Drug
Drug recall: Lupin, Eugia recalled products Due to Manufacturing Issues
Pharma Companies Under Scrutiny: New Rules for Marketing Practices
DCGI granted approval for Eye Drops to treat Presbyopia
Pakistan: Drug Production Quality Under Scrutiny, Concerns Raised in Senate Committee
NDPS: Illegal Drug Manufacturing Unit busted in East Godavari
USFDA issues EIR for Marksans Pharma Goa facility
Indian Pharma Industry: A Global Powerhouse
USFDA approval granted for generic drug for Scalp Psoriasis Treatment
Huge stock of medicines seized: DCA Telangana
FSSAI: Food Labelling and Display – Chapter-9
USFDA issues warning letter to Zydus for injectables unit at Jarod
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
